Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

8,823 evidence items · page 72 / 353

45.3 %The prevalence of onychomycosis among diabetic subjects was 45.3%.

Nigeriaonychomycosispublished 2024West African journal of medicinePubMeddocument of 6 observations

67.2 %In the MEND case-control study, 67.2% of Nigerian breast cancer cases were grade 2.

Nigeriacancer du seinpublished 2026Breast cancer research and treatmentPubMeddocument of 10 observations

4 %An impaired relaxation pattern was observed in 4.0% of the HIV group.

NigeriaVIH/sidapublished 2022BMC pediatricsPubMeddocument of 6 observations

2,000 per_μLAsexual parasite densities were highest in the northern geopolitical zones (geometric means > 2000 μL).

Nigeriapaludismeobserved 2018published 2023Scientific reportsPubMeddocument of 3 observations

27 %The high diversity microbiota, Community State Type IV-B, was the most prevalent in HIV-positive women (27% at baseline, 35% at follow-up).

Nigeriahigh diversity microbiota, Community State Type IV-Bpublished 2020Scientific reportsPubMeddocument of 6 observations

0 %Uptake of pap smear was 0.0% in the intervention group at baseline.

Nigeriacancer du col de l'utéruspublished 2022BMC women's healthPubMeddocument of 5 observations

81 %Cross-resistance to at least one of the newer NNRTIs—doravirine, etravirine or rilpivirine—was predicted in 81% of participants with HIV-1 who had failed first-line ART in Nigeria.

NigeriaVIH/sidapublished 2022The Journal of antimicrobial chemotherapyPubMeddocument of 9 observations

9.6 %The prevalence of diabetes mellitus among market traders in Jos North Local Government Area of Plateau State was 9.6%.

Nigeriadiabète (non précisé)published 2021Nigerian journal of clinical practicePubMeddocument of 9 observations

16.9 %Out of 144 cervical samples, 24 were positive for HPV16 by PCR, representing a molecular prevalence rate of 16.9%.

Nigeriainfection à HPVpublished 2022African health sciencesPubMeddocument of 2 observations

7.6 %In a cross-sectional study of 405 Nigerian children, 7.6% were homozygous for alpha+-thalassaemia.

Nigeriadrépanocytosepublished 2001Tropical medicine & international health : TM & IHeurope_pmcdocument of 8 observations

11 daysSD Bioline MPT64 achieved a shorter median time to identification of MTBC at 11 days compared to 26 days by the conventional method.

Nigeriatuberculosepublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 6 observations

16 %Glucose-6-phosphate dehydrogenase deficiency was present in 16% of hemizygous males (94/603) and 4% of homozygous females (22/598) among enrolled patients.

Nigeriaglucose-6-phosphate dehydrogenase deficiencypublished 2009PLoS ONEOpenAlexdocument of 9 observationsDOI 10.1371/journal.pone.0006682

5 %The likelihood of major depressive disorder increased by 5% for every point reduction in social support scores.

Nigeriamajor depressive disorderpublished 2022AIDS carePubMeddocument of 3 observations

68 %In a single-arm trial, self-reported adherence ≥90% among youth with HIV in Nigeria increased to 68% at 48 weeks (P = 0.031) compared with baseline.

NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

6.2 %Coexistence of hypertension and impaired fasting capillary glucose (IFCG) was prevalent among 6.2% of rural adolescents aged 10–19 years in southeast Nigeria.

Nigeriahypertension and impaired fasting capillary glucosepublished 2021BMJ openPubMeddocument of 5 observations

Malaria incidence and mortality data were used from the Malaria Atlas Project.

Nigeriapaludismepublished 2026Malaria journalPubMeddocument of 8 observations

81.3 %Among 370 HIV-positive individuals in Akwa Ibom state, Nigeria, 81.3% were not virally suppressed in 2017.

NigeriaVIH/sidaobserved 2017published 2021Journal of the International AIDS SocietyPubMeddocument of 9 observations

42.5 %Peripheral arterial disease occurred in 42.5% of 400 type 2 diabetes participants in a tertiary hospital in south west Nigeria.

Nigeriadiabète de type 2 · Peripheral arterial diseasepublished 2022The Pan African medical journalPubMeddocument of 16 observations

0 per_62Lassa-fever-specific IgM was detected in 0 out of 62 monkey serum samples collected between August 2015 and December 2017 in Southern Nigeria.

Nigeriafièvre de Lassaobserved August 2015 to December 2017published 2019Journal of epidemiology and global healtheurope_pmcdocument of 3 observations

7.2 %Forty-nine (7.2%) of 676 tuberculosis patients at the TB DOTS clinic of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, from January 2017 to December 2021 had unknown HIV status.

NigeriaVIH/sidaobserved 2017 to 2021published 2024West African journal of medicinePubMeddocument of 14 observations

69.1 %Hydroxyurea dose escalation beyond 20 mg/kg/day was required to attain significant reductions in the time-averaged mean of maximal velocities in 69.1% of the cases.

Nigeriadrépanocytosepublished 2021Pediatric blood & cancerPubMeddocument of 5 observations

150,000 infantsAn estimated 150,000 infants with sickle cell anemia are born annually in Nigeria.

Nigeriadrépanocytosepublished 2021Pediatric neurologyPubMeddocument of 4 observations

63.5 %63.5% of the participants showed good knowledge of cervical cancer screening and vaccination.

Nigeriacancer du col de l'utéruspublished 2023BMC women's healthPubMeddocument of 7 observations

5 %Among pregnant women in Nigeria, the probability of being in the worst-case scenario (fewer than four antenatal care visits and fewer than three intermittent preventive treatment with sulfadoxine-pyrimethamine doses) was 5% among the wealthiest women with higher education.

Nigeriapaludismeobserved 2018published 2026Malaria journalPubMeddocument of 9 observations

591,103,335 USDThe funding shortfall for national malaria interventions in Nigeria from 2018 to 2020 was $591,103,335, or 52.7% of the needs.

Nigeriapaludismeobserved 2018-2020published 2023A Conceptual Framework on the Role of Backward Integration in Sustainable Access to Malarieurope_pmcdocument of 9 observationsDOI 10.21203/rs.3.rs-2963622/v1

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.